TABLE 5.
Imipenem-relebactam MICs among Escherichia coli isolates susceptible or nonsusceptible to comparator agents
Comparator agenta | I-R MIC |
P valueb | |||||||
---|---|---|---|---|---|---|---|---|---|
Susceptible to comparator agent |
Nonsusceptible to comparator agent |
||||||||
MIC50 | MIC90 | Range | Mean | MIC50 | MIC90 | Range | Mean | ||
IPM | 0.25 | 0.5 | ≤0.03–1.0 | 0.27 | 0.25 | 32 | 0.06 to >256 | 19.3 | *** |
MEM | 0.25 | 1.0 | ≤0.03–2 | 0.35 | 0.5 | 64 | 0.12 to >256 | 43.1 | *** |
ETP | 1.0 | 2 | 0.12–32 | 5.2 | 0.25 | 2 | ≤0.03 to >256 | 11.1 | |
GEN | 0.25 | 1.0 | ≤0.03 to >256 | 9.1 | 0.25 | 32 | 0.06 to >256 | 14.1 | |
TZP | 0.25 | 1.0 | 0.06–2 | 0.32 | 0.25 | 32 | ≤0.03 to >256 | 15.0 | * |
AMK | 0.25 | 1 | ≤0.03 to >256 | 9.0 | 0.5 | 32 | 0.06 to >256 | 19.0 | ** |
LVX | 0.25 | 1 | 0.06–4 | 0.41 | 0.25 | 8 | ≤0.03 to >256 | 14.0 | |
TGC | 0.25 | 2 | ≤0.03 to >256 | 8.5 | 2 | > 256 | 0.5 to >256 | 172 | * |
CAZ | 0.5 | 2 | 0.125–2 | 0.59 | 0.25 | 4 | 0.25 to >256 | 12.0 | |
CL | 0.25 | 2 | ≤0.03 to >256 | 11.0 | 0.5 | 0.50 | 0.125–0.5 | 0.31 | |
MIN | 0.25 | 1.0 | 0.06–64 | 2.0 | 0.25 | 64 | ≤0.03 to >256 | 31.0 | * |
AMK, amikacin; CAZ, ceftazidime; CL, colistin; ETP, ertapenem; GEN, gentamicin; IPM, imipenem; I-R, imipenem-relebactam; LVX, levofloxacin; MEM, meropenem; MIN, minocycline; TGC, tigecycline; TZP, piperacillin-tazobactam.
P values as determined by Mann-Whitney test. *, P < 0.05; **, P < 0.01; ***, P ≤ 0.001.